Multidisciplinary treatment for esophageal cancer leads to nutritional and inflammatory
changes. Recent studies showed that nutritional and inflammatory changes during …

Background Systemic inflammation plays a role in carcinogenesis and is related to overall
survival in patients with different cancer types, including those treated with immune …

Background It is unclear whether the systemic inflammation response index (SIRI) can
predict the prognosis of patients with hepatocellular carcinoma (HCC). Consequently, the …

Simple Summary Several elements that are composed of, or related to, neutrophils, have
been shown to inhibit strong immune responses to cancer and promote cancers' growth …

Purpose Various blood cell parameters have been identified as predictive markers of tumor
responses and the survival of patients with cancer treated with immune checkpoint …

Background. Chemoimmunotherapy has become the first-line treatment for unresectable
esophageal squamous cell carcinoma (ESCC). Still, reliable biomarkers to identify patients …

Background The systemic inflammation score (SIS), based on serum albumin (Alb) and
lymphocyte-to-monocyte ratio (LMR), is a novel prognostic tool for some tumours. Studies …

Purpose This study aims to assess the prognostic value of inflammatory markers and clinical
features in advanced or metastatic esophageal squamous cell carcinoma (ESCC) patients …

Background The real-world efficacy, feasibility, and prognostic factors of immune-checkpoint
inhibitor combination therapy for unresectable or metastatic esophageal cancer are not fully …

Objectives The role of the Controlling Nutritional Status (CONUT) scores in predicting the
prognosis of lymphoma cases has been extensively explored, with no consistent results. The …